How much does a box of Mobosetinib/Mobosetinib cost in 2024?

Mobocertinib is an oral small molecule tyrosine kinase inhibitor (TKI) targeting EGFR Exon20 insertion mutations. It is specifically designed for the treatment of lung cancer that selectively targets EGFR Exon20 insertion mutations. The drug is a kinase inhibitor that blocks the action of abnormal proteins that signal cancer cells to proliferate, preventing or slowing the spread of cancer cells and shrinking tumors.

In China, mobosertinib has been approved by the National Medical Products Administration for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have progressed during or after platinum-containing chemotherapy and carry epidermal growth factor receptor (EGFR) exon 20 insertion mutations. Mobosetinib has shown impressive potential in the treatment of lung cancer, especially for patients with non-small cell lung cancer harboring EGFR gene mutations. As a third-generation EGFR inhibitor, mobotinib can interfere with the EGFR signaling pathway, thereby inhibiting the growth and division of cancer cells. The drug performs well in treating related diseases, with significant efficacy and high safety.

Mobosetinib The original drug has been launched in China, but it is not included in the medical insurance. The price of the common specification 40mg*112 pills per box is about 40,000 yuan, which is very high. The Hong Kong clinical version specification 40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. Its pharmaceutical ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory 40mg*120 pills per box may be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.